ZoomInfo (GTM) insider sale: 14,290 shares ($146,758)
ZoomInfo Technologies Inc. insider filing reports a proposed sale of 14,290 common shares under Rule 144 through Morgan Stanley Smith Barney LLC on 10/02/2025, with an aggregate market value of $146,758.30 based on outstanding common shares of 318,630,783.
Rhea-AI Filing Summary
ZoomInfo Technologies Inc. insider filing reports a proposed sale of 14,290 common shares under Rule 144 through Morgan Stanley Smith Barney LLC on 10/02/2025, with an aggregate market value of $146,758.30 based on outstanding common shares of 318,630,783. The shares were acquired as Restricted Stock Units on 10/01/2025 and show a same-day acquisition and proposed sale timing. The filing identifies prior 10b5-1 sales by James M. Roth on 09/03/2025 of 3,288 shares for gross proceeds of $33,731.59. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information.
Positive
- Timely disclosure of proposed sale through Rule 144 via an established broker
- Inclusion of 10b5-1 history (prior sale of 3,288 shares) provides trading transparency
Negative
- Insider sale of 14,290 shares valued at $146,758.30 could be viewed unfavorably by some investors
- Same-day acquisition and proposed sale (acquired 10/01/2025; proposed sale 10/02/2025) may raise questions about timing
Insights
Insider plans to sell 14,290 shares, totaling $146,758.30.
The filing documents a proposed Rule 144 sale of 14,290 shares via Morgan Stanley Smith Barney on 10/02/2025. The shares were reported as acquired on 10/01/2025 as Restricted Stock Units, indicating recent vesting.
This notice also records prior 10b5-1 sales of 3,288 shares on 09/03/2025 for $33,731.59, showing recent execution activity. The filing itself is procedural disclosure required under securities rules.
Filing includes the required attestation about material information and a trading-plan reference.
The form contains the standard representation that the seller does not possess undisclosed material adverse information and references Rule 10b5-1 sales, which aligns with compliance protocols for planned insider sales.
No statements in the filing assert any undisclosed material facts; the document fulfills statutory notice obligations for the proposed transaction.
FAQ
What does the Form 144 for ZoomInfo (GTM) report?
Who is the seller named in the Form 144?
Does the Form 144 indicate undisclosed material information?
AI-generated analysis. How Rhea-AI works. Not financial advice.